EndoChoice Awarded GI Contract With the Premier Healthcare Alliance

ALPHARETTA, GA--(Marketwire - Jan 22, 2013) - EndoChoice, Inc. announced today that it has been awarded a group purchasing agreement with the Premier Healthcare Alliance for its gastrointestinal (GI) devices and supplies. Starting February 1^st, the new agreement allows Premier members to take advantage of special pricing and terms pre-negotiated by Premier for gastroenterology products. 

"EndoChoice is focused solely on the gastrointestinal endoscopy market, giving us unique insight into the needs and challenges of specialists treating a wide range of gastrointestinal diseases," said Gregg Costantino, Vice President of Sales. "We are pleased to partner with Premier to offer its members access to our extensive product line including many of the preferred devices and supplies in GI endoscopy."

EndoChoice has experienced exponential growth since its founding in 2008 by a team of experienced medical device professionals. For the past three years, Inc. Magazine has ranked EndoChoice as one of the fastest growing companies in America. 

About the Premier Healthcare Alliance, Malcolm Baldridge National Quality Award recipient

Premier is a performance improvement alliance of more than 2,700 U.S. hospitals and 90,000 other sites using the power of collaboration and technology to lead the transformation to coordinated, high-quality, cost-effective care. Owned by hospitals, health systems and other providers, Premier operates a leading healthcare purchasing network with more than $4 billion in annual savings. Premier also maintains the nation's largest clinical, financial and outcomes database with information on 1 in 4 patient discharges. A world leader in delivering measurable improvements in care, Premier works with the Centers for Medicare & Medicaid Services. Headquartered in Charlotte, N.C., Premier also has an office in Washington. www.premierinc.com.

About EndoChoice

EndoChoice, a platform-technology company, provides devices, diagnostics, infection control and imaging for specialists treating a wide range of gastrointestinal diseases. EndoChoice currently has over 2,500 customers and distribution in 34 countries worldwide, and was recently recognized for the third consecutive year as one of the fastest growing companies in the U.S. by Inc. Magazine. To learn more, visit www.endochoice.com.